What we’re reading (10/2)

• “Trump Taken To Walter Reed Medical Center And Will Be Hospitalized ‘For The Next Few Days’” (CNN). “President Donald Trump arrived Friday evening at Walter Reed National Military Medical Center, where the White House says he will remain hospitalized for ‘the next few days’” [after announcing he and the First Lady had tested positive for COVID-19].

• “What We Know — And Don’t — About Trump’s Covid Case” (Politico). “President Donald Trump's coronavirus diagnosis has underscored the unpredictable nature of the disease — and how the oldest elected president in U.S. history, who's just above the CDC threshold for obesity, is at increased risk of developing complications.”

• “Invincibility Punctured By Infection: How The Coronavirus Spread In Trump’s White House” (Washington Post). “The ceremony in the White House Rose Garden last Saturday was a triumphal flashback to the Before Times — before public health guidelines restricted mass gatherings, before people were urged to wear masks and socially distance. President Trump and first lady Melania Trump welcomed more than 150 guests as the president formally introduced Judge Amy Coney Barrett, his nominee for the Supreme Court.”

• “Trump Receives Experimental Coronavirus Treatment As Drug Companies Seek The Right Approach To Mild And Moderate Forms Of COVID-19” (MarketWatch). “After testing positive for the coronavirus, President Donald Trump was given a dose of Regeneron Pharmaceuticals Inc.’s experimental neutralizing antibody cocktail, considered one of the most promising candidates to fill a major hole in COVID-19 treatment plans.”

• “Here’s Everything We Know About The Unapproved Antibody Drug Trump Took To Combat Coronavirus” (CNBC). “Former Food and Drug Administration commissioner Dr. Scott Gottlieb told CNBC on Friday he believes the White House carefully considered all of its treatment options before it opted to give President Donald Trump the experimental coronavirus antibody cocktail from Regeneron Pharmaceuticals.”